Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan in Fontan-Palliated Adolescents and Adults
CTR20180367Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of macitentan in Fontan failure, Single Ventricle Heart Defects, sponsored by Actelion Pharmaceuticals Ltd. Started Oct 2018; status: completed.
02
Drugs
macitentan
03
Conditions
Fontan failureSingle Ventricle Heart Defects
Beyond the preview
Go deeper on CTR20180367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180367.